JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Accueil・Liste d'Actions・Boston Scientific Corp.

Boston Scientific Corp.

Fermé

SecteurSoins de santé

55.97 -1.62

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

55.87

Max

56.99

Chiffres clés
By Trading Economics
Revenu	-83M 672M
Ventes	-83M 5.2B
P/E Moyenne du Secteur	25.084 67.147
BPA	0.8
Marge bénéficiaire	12.713
Employés	59,000
EBITDA	116M 1.1B

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+56.76% upside

Dividendes
By Dow Jones
Prochains Résultats	29 juil. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-1.5B 89B
Ouverture précédente	57.59
Clôture précédente	55.97

Sentiment de l'Actualité

By Acuity

51%

49%

281 / 347 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

102.95 / 104.93 Support & Résistance

Boston Scientific Corp. Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 avr. 2026, 11:22 UTC

Résultats

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adjusted EPS View

4 févr. 2026, 16:14 UTC

Résultats

Principaux Mouvements du Marché

Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat

4 févr. 2026, 12:13 UTC

Résultats

Boston Scientific Sees More Growth after Earnings, Sales Rise

22 avr. 2026, 11:07 UTC

Résultats

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adj EPS View

22 avr. 2026, 10:32 UTC

Résultats

Boston Scientific Now Sees 2026 Reported Sales Up 7%-8.5%, Organic Sales Up 6.5%-8% >BSX

22 avr. 2026, 10:31 UTC

Résultats

Boston Scientific Sees 2Q Reported Sales Up 5.5%-7.5%, Organic Sales Up 5%-7% >BSX

22 avr. 2026, 10:30 UTC

Résultats

Boston Scientific 1Q Organic Sales Up 9.4% >BSX

22 avr. 2026, 10:30 UTC

Résultats

Boston Scientific 1Q Adj EPS 80c >BSX

22 avr. 2026, 10:30 UTC

Résultats

Boston Scientific 1Q EPS 90c >BSX

22 avr. 2026, 10:30 UTC

Résultats

Boston Scientific 1Q Sales $5.2B >BSX

22 avr. 2026, 10:30 UTC

Résultats

Boston Scientific Sees 2Q Adj EPS 82c-Adj EPS 84c >BSX

22 avr. 2026, 10:30 UTC

Résultats

Boston Scientific Sees FY Adj EPS $3.34-Adj EPS $3.41 >BSX

30 mars 2026, 15:34 UTC

Market Talk

Boston Scientific Faces Some Slowing Growth Trends -- Market Talk

4 févr. 2026, 21:41 UTC

Résultats

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 févr. 2026, 19:38 UTC

Résultats

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 févr. 2026, 17:32 UTC

Résultats

These Stocks Are Today's Movers: AMD, AbbVie, Eli Lilly, Boston Scientific, MP Materials, Super Micro, Silicon Labs, Uber, and More -- Barrons.com

4 févr. 2026, 15:30 UTC

Résultats

Boston Scientific Earnings Beat Estimates. It's the Worst Stock in the S&P 500 Today. -- Barrons.com

4 févr. 2026, 15:29 UTC

Résultats

These Stocks Are Today's Movers: AMD, Eli Lilly, AbbVie, Uber, Super Micro, Enphase, Boston Scientific, and More -- Barrons.com

4 févr. 2026, 14:06 UTC

Résultats

Boston Scientific Profit, Sales Rise but Issues Soft Guidance -- Update

4 févr. 2026, 13:58 UTC

Résultats

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

4 févr. 2026, 13:12 UTC

Résultats

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

4 févr. 2026, 11:32 UTC

Résultats

Boston Scientific Sees 2026 Sales Up 10.5%-11.5%, Organic Sales Up 10%-11% >BSX

4 févr. 2026, 11:31 UTC

Résultats

Boston Scientific Sees 1Q Sales Up 10.5%-12%, Organic Sales Up 8.5%-10% >BSX

4 févr. 2026, 11:30 UTC

Résultats

Boston Scientific 4Q Organic Sales Up 12.7% >BSX

4 févr. 2026, 11:30 UTC

Résultats

Boston Scientific Sees 2026 Adj EPS $3.43-Adj EPS $3.49 >BSX

4 févr. 2026, 11:30 UTC

Résultats

Boston Scientific Sees 1Q Adj EPS 78c-Adj EPS 80c >BSX

4 févr. 2026, 11:30 UTC

Résultats

Boston Scientific 4Q Adj EPS 80c >BSX

4 févr. 2026, 11:30 UTC

Résultats

Boston Scientific 4Q Sales $5.29B >BSX

4 févr. 2026, 11:30 UTC

Résultats

Boston Scientific 4Q EPS 45c >BSX

24 janv. 2026, 06:18 UTC

Acquisitions, Fusions, Rachats

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

Comparaison

Variation de prix

Boston Scientific Corp. prévision

Objectif de Prix

By TipRanks

56.76% hausse

Prévisions sur 12 Mois

Moyen 89.12 USD 56.76%

Haut 118 USD

Bas 71 USD

Basé sur 27 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

27 ratings

Achat

Maintien

Vente

Basé sur 27 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

102.95 / 104.93Support & Résistance

All events are bullish.

Recent bearish events outweigh bullish events.

There are no events.

Sentiment

By Acuity

281 / 347Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.